Ketamine enantiomers in the rapid and sustained antidepressant effects

Therapeutic Advances in Psychopharmacology

Volumn 6, Issue 3, 2016, Pages 185-192

  Muller, John ^a   Pentyala, Sahana ^a   Dilger, James ^a   Pentyala, Srinivas ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

depression; electroconvulsive therapy; ketamine

Indexed keywords

KETAMINE; PLACEBO;

ABUSE; AGITATION; ANTIDEPRESSANT ACTIVITY; BECK DEPRESSION INVENTORY; BIPOLAR DEPRESSION; BRAIN DAMAGE; BRIEF PSYCHIATRIC RATING SCALE; COGNITIVE DEFECT; CONFUSION; CYSTITIS; DEPRESSION; DISSOCIATIVE DISORDER; DIZZINESS; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; ELEVATED BLOOD PRESSURE; ENANTIOSELECTIVITY; EUPHORIA; HAMILTON DEPRESSION RATING SCALE; HUMAN; LETHARGY; LIBIDO; LIVER INJURY; LOCOMOTION; MAJOR DEPRESSION; MEMORY DISORDER; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NONHUMAN; PERCEPTION DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIDE EFFECT; STEREOISOMERISM; SYNAPTOGENESIS; TREATMENT RESISTANT DEPRESSION;

EID: 85006212213     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125316631267     Document Type: Review

References (41)

1. H.Adams (1997) S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia-sedation. Anaesthesist46: 1081.
2. C.Andrade (2015) Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression. J Clin Psychiatry76: 628–631.
3. A.AutryM.AdachiE.Nosyreva. (2011) NMDA receptor blockade at rest triggers rapid behavioral antidepressant responses. Nature475: 95.
4. R.BermanA.CappielloA.AnandD.OrenG.HeningerD.Charney. (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351–354.
5. T.Calvey (1995) Isomerism and anaesthetic drugs. Acta Anaesthesiol Scand Suppl106: 83.
6. J.ClemensW.NimmoI.Grant (1982) Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. Pharm Sci71: 539–542.
7. N.DiazgranadosL.IbrahimN.BrutscheA.NewbergP.KronsteinS.Khalife. (2010) A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry67: 793–802.
8. E.Domino (2010) Taming the ketamine tiger. Anesthesiology113: 678–686.
9. S.EdwardsL.Mather (2001) Tissue uptake of ketamine and norketamine enantiomers in the rat: indirect evidence for extrahepatic metabolic inversion. Life Sci69: 2051.
10. M.GhasemiM.KazemiA.YoosefiA.GhasemiP.ParagomiH.Amini. (2014) Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder. Psychiatry Res215: 355–361.
11. C.HaileJ.MurroughD.IosifescuL.ChangR.Al JurdiA.Foulkes. (2014) Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol17: 331–336.
12. S.HassamalM.SpiveyA.Pandurangi (2015) Augmentation therapy with serial intravenous ketamine over 18 months in a patient with treatment resistant depression. Clin Neuropharmacol38: 212–216.
13. A receptors containing α6 and δ subunits. J Neurosci28: 5383–5393.
14. N.IadarolaM.NiciuE.RichardsJ.Vande VoortE.BallardN.Lundin. (2015) Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review. Ther Adv Chronic Dis6: 97–114.
15. K.Jansen (2000) A review of the nonmedical use of ketamine: use, users and consequences. J Psychoactive Drug32: 419–433.
16. D.JonesK.NguyenM.McLeishD.CrankshawD.Morgan (1996) Determination of (R)-(+)- and (S)-(–)-isomers of thiopentone in plasma by chiral high-performance liquid chromatography,J Chromatogr B Biomed Appl675: 174.
17. C.KellnerR.GreenbergJ.MurroughE.BrysonM.BriggsR.Pasculli (2012) ECT in treatment-resistant depression. Am J Psychiatry169: 1238–1244.
18. R.KesslerP.BerglundO.Demler (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA289: 3095–3105.
19. N.LiB.LeeR.LiuM.BanasrJ.DwyerM.Iwata. (2010) mTOR dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science329: 959–964.
20. D.LuckenbaughM.NiciuD.IonescuN.NolanE.RichardsN.Brutsche. (2014) Do the dissociative side effects of ketamine mediate its antidepressant effects?J Affect Dis159: 56–61.
21. R.LydicH.Baghdoyan (2002) Ketamine and MK-801 decrease acetylcholine release in the pontine reticular formation, slow breathing, and disrupt sleep. Sleep25: 617–622.
22. B.McEwen (2008) Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol583: 174–185.
23. P.ModicaR.TempelhoffP.White (1990) Pro- and anticonvulsant effects of anesthetics (part II). Anesth Analg70: 433.
24. M.NaughtonG.ClarkeO.O’LearyJ.CryanT.Dinan (2014) A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanism of action. J Affect Dis156: 24–35.
25. N.OkamotoT.NakaiK.SakamotoY.NagafusaT.HiguchiT.Nishikawa. (2010) Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT26: 223–227.
26. E.PfenningerM.DurieuxS.Himmelsehe (2002) Cognitive impairment after small-dose ketamine isomers in comparison to equianalgesic racemic ketamine in human volunteers. Anesthesiology96: 357.
27. K.RasmussenM.JarvisC.Zorumski (1996) Ketamine anesthesia in ECT. Convuls Ther12: 217–223.
28. K.RasmussenS.KungM.LapidT.OesterleJ.GeskeG.Nuttall. (2014) A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy. Psychiatry Res215: 362–365.
29. A.Rezvani (2006) Involvement of the NMDA system in learning and memory. In: (eds), Animal Models of Cognitive Impairment. Boca Raton, FL: CRC Press, pp. 37–48.
30. M.RobsonM.ElliottM.SeminerioR.Matsumoto (2012) Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. Eur Neuropsychopharmacol22: 308–317.
31. J.SleighM.HarveyL.VossB.Denny (2014) Ketamine – more mechanisms of action than just NMDA blockade. Trends Anaesth Crit Care4: 76–81.
32. S.TanW.LamM.WaiW.YuD.Yew (2012) Chronic ketamine administration modulates midbrain dopamine system in mice. PLOS One7: e43947.
33. A.ThierryY.GioanniE.DégénétaisJ.Glowinski (2000) Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus10: 411–419.
34. F.VollenweiderK.LeendersI.OyeD.HellJ.Angst (1997) Differential psychopathology and patterns of cerebral glucose utilization produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol7: 25–38.
35. J.VuykE.SitsenM.Reekers (2015) Intravenous anesthetics. In: (ed.), Miller’s Anesthesia, 8th ed.Philadelphia, PA: Elsevier Saunders, pp. 821–828.
36. P.WhiteJ.HamW.WayA.Trevor (1980) Pharmacology of ketamine isomers in surgical patients. Anesthesiology52: 231.
37. P.WhiteJ.SchuttlerA.ShaferD.StanskiY.HoraiA.Trevor (1985) Comparative pharmacology of the ketamine isomers. Studies in volunteers. Br J Anaesth57: 197.
38. C.YangY.ShirayamaJ.ZhangQ.RenW.YaoM.Ma. (2015) R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry5: 1–11.
39. C.ZarateJrJ.SinghP.Carlson (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment resistant major depression. Arch Gen Psychiatry63: 856–864.
40. J.ZhangS.LiK.Hashimoto (2014) R (–)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine. Pharmacol Biochem Behav116: 137–141.
41. S.ZielmannS.KazmaierS.SchnullA.Weyland (1997) S-(+)-ketamine and circulation. Anaesthesist46(Suppl. 1): S43.